Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Obesity

Fasting, eating earlier in the day or eating fewer meals – what works best for weight loss?

Globally, one in eight people are living with obesity. This is an issue because excess fat increases the risk of type 2 diabetes, heart disease and certain cancers.

The Conversation

Robert F. Kennedy Jr. Plans FDA Reform To Tackle Obesity

Robert F. Kennedy Jr. plans FDA reform targeting ultra-processed foods to address health concerns and potential corruption allegations.

Top News

Obesity Drug Maker Novo Nordisk Posts Strong Profit

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by production constraints.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Pregnant Mothers With Obesity And PCOS At Higher Risk Of Having Smaller Babies: Study

On average, babies born to mothers with PCOS faced a higher risk of growth restriction, and the effects were more pronounced in mothers who were obese.

Medical Daily

Growing number of children leaving primary school underweight, new data says

Obesity in reception-age children also twice as high in deprived areas compared to affluent parts of England

The Independent UK

Children as young as two treated for obesity-related illness in England

NHS data shows one in 10 reception-age pupils now have obesity as experts warn of public health crisis

The Guardian - UK

Obesity among children leaving primary school falls for third year in a row

The data is from the Government’s national child measurement programme, which covers mainstream state-maintained schools in England.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Chinese Slimmers Trim Down At Weight-loss Camps

Yang Chi'ao takes her place next to gym equipment and waits to be called by an instructor at a weight-loss camp in China, where over half of adults are overweight.

International Business Times

Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat

Viking Therapeutics reported strong weight loss for higher doses of its experimental obesity drug.

Investors Business Daily

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy

Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a…

Barchart

Weight loss drugs may cause addiction switching, says award-winning therapist

Labour’s plans to give weight loss drugs to the unemployed may not just fail: it could backfire, therapist Sally Baker explains

Evening Standard

JD Vance Suggests Democrats Want Americans To Be Unhealthy For Liberalism

Republican VP candidate JD Vance's comments on health, obesity, and political ideologies spark debate and highlight the need for evidence-based discussions.

Top News

Up 285% YTD, Is It Too Late to Buy This Biotech Stock?

Viking Therapeutics is making notable advancements in obesity treatment with VK2735 and exploring strategic partnerships for its NASH program, positioning itself at the forefront of metabolic and endocrine disorder therapies

Barchart

Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO

Amgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. Amgen stock rose early Thursday.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Five reasons weight-loss jabs alone won’t help get people back to work

Prime Minister Keir Starmer and health secretary Wes Streeting have recently discussed plans to trial weight-loss injections for around 250,000 people with obesity who are unemployed in a bid to get them back into work, ease pressure on the NHS and boost the economy.

Investors Business Daily

Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.

Pfizer is taking on Amgen with its next steps in weight loss, the pharma titan said Tuesday as Pfizer stock dipped despite its beat.

Evening Standard

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections

As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama is shedding light on the pharmaceuticals industry behind them

Dynamite News

New blood test could identify children at risk of diabetes, liver ills

Scientists have developed a novel blood test that uses lipids to identify children who are more susceptible to obesity-related problems like diabetes. Read further on Dynamite News:

Get all your
news in one place.

100’s of premium titles.
One news app.

Medical Daily

GLP-1 Drugs For Obesity Treatment Reduce Bariatric Surgeries By 25%: Study

The study noted that a vast majority of obese patients, strikingly 94.7%, received neither form of treatment, while 5% received GLP-1 RAs and 0.3% received surgery.

The Guardian - UK

Force food firms to disclose products’ health ratings, industry boss urges

Exclusive: Stéfan Descheemaeker of Nomad Foods says mandatory rules could help kickstart ‘nutrition arms race’

Investors Business Daily

Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet

Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly's experimental triple.

Evening Standard

Doctors urged to look out for weight loss jab ‘misuse’

The medicines regulator has also urged medics to warn patients of side effects.

Evening Standard

Fine businesses not following anti-obesity rules on healthy food, peers say

The proposals came from the Lords’ Food, Diet and Obesity Committee.

StockNews.com

Is Eli Lilly Still a Top Healthcare Stock After Its Blockbuster Drug Approval?

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

Medical Daily

History Of Eating Disorders, Pre-Pregnancy Obesity Raises Offspring's Risk Of Mental Health Diagnosis

The study found associations between a mother's history of eating disorders and pre-pregnancy body mass index (BMI) higher than the normal weight range to most of the nine psychiatric diagnoses examined in the offspring.

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

179 stories

Novo

171 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.